Primary lung cancer | Metastatic lung tumor | Total | |
---|---|---|---|
Number | 164 patients | 37 patients | 201 patients |
Median age (y) | 78 (range: 40–92) | 63 (range: 25–85) | 76 (range: 25–92) |
Gender | |||
Female | 39 (23%) | 13 (35%) | 52 (25%) |
Male | 125 (76%) | 24 (64%) | 149 (74%) |
ECOG performance status | |||
0-1 | 142 (86%) | 37 (100%) | 179 (89%) |
2-3 | 22 (13%) | 0 (0%) | 22 (10%) |
History of other malignancies | |||
Yes | 81 (49%) | 6 (16%) | 87 (43%) |
No | 83 (50%) | 31 (83%) | 114 (56%) |
Pack-year smoking | Median 37.5 (range: 0–180) | ||
Never | 35 (21%) | 10 (43%) | 45 (24%) |
< 37.5 | 35 (21%) | 10 (43%) | 45 (24%) |
≥ 37.5 | 88 (55%) | 5 (20%) | 93 (50%) |
FEV1, % of predicted | Median 92.5 (range: 25.1-203.6) | ||
< 92 | 54 (47%) | 4 (66%) | 58 (48%) |
≥ 92 | 60 (52%) | 2 (33%) | 62 (51%) |
Home oxygen therapy | 13 | 0 | 13 (6%) |
Operability | |||
Operable | 64 (39%) | 20 (54%) | 84 (41%) |
Inoperable | 100 (60%) | 17 (45%) | 117 (58%) |